BEAM
Price
$17.21
Change
+$0.98 (+6.04%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.63B
95 days until earnings call
FOLD
Price
$6.09
Change
-$0.00 (-0.00%)
Updated
May 8, 04:59 PM (EDT)
Capitalization
1.87B
83 days until earnings call
Ad is loading...

BEAM vs FOLD

Header iconBEAM vs FOLD Comparison
Open Charts BEAM vs FOLDBanner chart's image
Beam Therapeutics
Price$17.21
Change+$0.98 (+6.04%)
Volume$51.12K
Capitalization1.63B
Amicus Therapeutics
Price$6.09
Change-$0.00 (-0.00%)
Volume$228.28K
Capitalization1.87B
BEAM vs FOLD Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. FOLD commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and FOLD is a Hold.

Ad is loading...
COMPARISON
Comparison
May 09, 2025
Stock price -- (BEAM: $17.25 vs. FOLD: $6.09)
Brand notoriety: BEAM and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 119% vs. FOLD: 152%
Market capitalization -- BEAM: $1.63B vs. FOLD: $1.87B
BEAM [@Biotechnology] is valued at $1.63B. FOLD’s [@Biotechnology] market capitalization is $1.87B. The market cap for tickers in the [@Biotechnology] industry ranges from $301.75B to $0. The average market capitalization across the [@Biotechnology] industry is $2.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than FOLD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 5 TA indicator(s) are bullish while FOLD’s TA Score has 4 bullish TA indicator(s).

  • BEAM’s TA Score: 5 bullish, 4 bearish.
  • FOLD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than FOLD.

Price Growth

BEAM (@Biotechnology) experienced а -13.01% price change this week, while FOLD (@Biotechnology) price change was -20.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.65%. For the same industry, the average monthly price growth was +15.24%, and the average quarterly price growth was -12.41%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

FOLD is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (-3.65% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FOLD($1.87B) has a higher market cap than BEAM($1.63B). BEAM YTD gains are higher at: -30.444 vs. FOLD (-35.350). FOLD has higher annual earnings (EBITDA): 29.4M vs. BEAM (-383.98M). BEAM has more cash in the bank: 851M vs. FOLD (250M). BEAM has less debt than FOLD: BEAM (161M) vs FOLD (444M). FOLD has higher revenues than BEAM: FOLD (528M) vs BEAM (63.5M).
BEAMFOLDBEAM / FOLD
Capitalization1.63B1.87B87%
EBITDA-383.98M29.4M-1,306%
Gain YTD-30.444-35.35086%
P/E RatioN/AN/A-
Revenue63.5M528M12%
Total Cash851M250M340%
Total Debt161M444M36%
FUNDAMENTALS RATINGS
FOLD: Fundamental Ratings
FOLD
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
93
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMFOLD
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
61%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 15 days ago
79%
Bullish Trend 9 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
70%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
78%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IVOIX17.720.15
+0.85%
Macquarie Mid Cap Income Opps I
JORCX17.020.06
+0.35%
Janus Henderson Global Select C
AULRX73.52N/A
N/A
American Century Ultra® R
MOJCX13.02N/A
N/A
Donoghue Forlines Momentum C
JERNX11.69-0.09
-0.76%
Janus Henderson Global Real Estate N